ホーム › がん（全種類） › ミズーリ州 › St. Louis
St. Louis、MOにおけるがん（全種類）の臨床試験
St. Louisとその周辺地域（約30マイル以内）の拠点で、がん（全種類）に関する46件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
A Study of ASP3082 in Adults With Advanced Solid Tumors
被験者募集中第1相
- Washington University School of Medicine, St Louis
Online Perioperative Education Program on Patient Satisfaction and Clinical Outcomes for Head and Neck Surgery
被験者募集中
- Washington University School of Medicine, St Louis
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
被験者募集中第1相
- Washington University School of Medicine - Oncology Hospital - Public, St Louis
A Study of PHN-012 in Patients With Advanced Solid Tumors
被験者募集中第1相
- PHN-012-001 Site, St Louis
Registry Study for Radiation Therapy Outcomes
被験者募集中観察研究
- Mercy David C. Pratt Cancer Center, St Louis
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
被験者募集中観察研究
- Washington University, St Louis
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
被験者募集中第2/3相
- Cancer Care Specialists of Illinois - Cancer Care Center of O'Fallon, O'Fallon · 16マイル先
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
被験者募集中第2/3相
- Siteman Cancer Center, St Louis
Collection of Tissue Samples for Cancer Research
被験者募集中観察研究
- Washington University - St. Louis, St Louis
Replacing Invasive Cystoscopy With Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance
被験者募集中第2相
- VA St.Louis Healthcare System, St Louis
A Study to Investigate Safety and Effectiveness of Tacabrutideg (BGB-16673) in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies
被験者募集中第1/2相
- Washington University School of Medicine, St Louis
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
被験者募集中第1/2相
- Research Site, St Louis
A Phase 1/1b Study of IAM1363 in HER2 Cancers
被験者募集中第1相
- Washington University School of Medicine, St Louis
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
被験者募集中第1相
- Washington University School of Medicine, St Louis
HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
被験者募集中第1相
- Siteman Cancer Center at Washington University, St Louis
A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
被験者募集中観察研究
- Washington University in St. Louis, St Louis
Project: Every Child for Younger Patients With Cancer
被験者募集中観察研究
- Cardinal Glennon Children's Medical Center, St Louis
- Washington University School of Medicine, St Louis
- Mercy Hospital Saint Louis, St Louis
Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer
被験者募集中第3相
- Renown Regional Medical Center, St Louis
FOG-001 in Locally Advanced or Metastatic Solid Tumors
被験者募集中第1/2相
- Washington University School of Medicine, St Louis
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
被験者募集中第3相
- Mercy Infusion Center - Chippewa, St Louis
- Washington University School of Medicine, St Louis
- Mercy Hospital South, St Louis
- 他5件
IDOV-Immune for Advanced Solid Tumors
被験者募集中第1相
- Washington University School of Medicine, St Louis
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
被験者募集中第2相
- 521, St Louis
Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors
被験者募集中第1/2相
- Washington University, St Louis
A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors
被験者募集中第1相
- Washington University School of Medicine, St Louis
CARE Tool Study Aim 3
被験者募集中
- Washington University School of Medicine, St Louis
- Alton Memorial Hospital, Alton · 18マイル先
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
被験者募集中第1/2相
- Washington University, St Louis
Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)
被験者募集中観察研究
- Mercy Hospital - South, St Louis
- Mercy Hospital -STL, St Louis
Childhood Cancer Survivor Study
被験者募集中観察研究健康なボランティア歓迎
- St. Louis Children's Hospital/The Washington University, St Louis
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
被験者募集中
- St. Louis VA Medical Center John Cochran Division, St. Louis, MO, St Louis
Patients At Risk for Sensory Screening (HPARSS) to Enhance Sensory Deficit Screening in Childhood Cancer Survivors
被験者募集中
- St. Louis Children's Hospital - Washington University School of Medicine, St Louis
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
被験者募集中第1/2相
- Washington University, St Louis
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
被験者募集中第1相
- Research Site, St Louis
An AI-Generated, Personalized Question Prompt List Intervention for Patients With Hematologic Cancers
被験者募集中
- Washington University School of Medicine, St Louis
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
被験者募集中第1/2相
- Washington University Infusion Center Pharmacy, St Louis
Galleri® in the Medicare Population.
被験者募集中健康なボランティア歓迎
- Mercy Health St. Louis, St Louis
Patient Position Monitoring System for Beam Gated Radiation Therapy of Malignancies of the Chest and Upper Abdomen
被験者募集中観察研究
- Washington University School of Medicine, St Louis
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
被験者募集中第1相
- Washington University School of Medicine, St Louis
TEMPUS ARIES: A Biobank Registry Platform Study in Oncology
被験者募集中観察研究
- Cancer Care Specialists of Illinois, O'Fallon · 16マイル先
Cancer Care Companion
被験者募集中
- Washington University School of Medicine/Saint Louis Children's Hospital, St Louis
GEMINI-NSCLC: NSCLC Biomarker Study
被験者募集中観察研究
- Mercy Clinic Oncology and Hematology - Sindelar Cancer Center, St Louis
- Mercy Clinic Oncology and Hematology - David C. Pratt Cancer Center, St Louis
Beat Childhood Cancer Specimen Banking and Data Registry
被験者募集中観察研究健康なボランティア歓迎
- Cardinal Glennon Children's Hospital, St Louis
Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors
被験者募集中第1相
- Washington University Medical Campus, St Louis
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
被験者募集中観察研究
- Massive Bio SYNERGY-AI site, St Louis
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
被験者募集中第1/2相
- Washington University, St Louis
Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays
被験者募集中観察研究
- Washington University School of Medicine, St Louis
- Mercy Clinic Oncology and Hematology - Sindelar Cancer Center, St Louis
- Mercy Clinic Oncology and Hematology - David C. Pratt Cancer Center, St Louis
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
被験者募集中
- Washington University School of Medicine, St Louis
- Siteman Cancer Centre, Barnes Jewish West County, Creve Coeur · 12マイル先
他の都市におけるがん（全種類）の試験
- Houston, TX121件の研究
- New York City, NY109件の研究
- Boston, MA85件の研究
- Los Angeles, CA74件の研究
- Nashville, TN65件の研究
- Philadelphia, PA59件の研究
- Washington, DC58件の研究
- Durham, NC58件の研究
- Chicago, IL51件の研究
- Atlanta, GA49件の研究
- Seattle, WA49件の研究
- Arlington, VA48件の研究
St. Louisにおける他の研究
- 非小細胞肺癌73件の研究
- 乳がん64件の研究
- 転移性癌54件の研究
- 大腸癌50件の研究
- 前立腺がん46件の研究
- 肺がん39件の研究
- 卵巣がん38件の研究
- 膵臓がん33件の研究
- 子宮内膜がん29件の研究
- 頭頸部扁平上皮癌28件の研究
- 心不全26件の研究
- 肥満症25件の研究
ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。